chr1-25246771-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020317.5(RSRP1):āc.193C>Gā(p.Arg65Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,611,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020317.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RSRP1 | NM_020317.5 | c.193C>G | p.Arg65Gly | missense_variant | 2/5 | ENST00000243189.12 | NP_064713.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RSRP1 | ENST00000243189.12 | c.193C>G | p.Arg65Gly | missense_variant | 2/5 | 1 | NM_020317.5 | ENSP00000243189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000304 AC: 76AN: 250310Hom.: 0 AF XY: 0.000310 AC XY: 42AN XY: 135608
GnomAD4 exome AF: 0.000152 AC: 222AN: 1459106Hom.: 0 Cov.: 31 AF XY: 0.000164 AC XY: 119AN XY: 725330
GnomAD4 genome AF: 0.000250 AC: 38AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.193C>G (p.R65G) alteration is located in exon 2 (coding exon 1) of the RSRP1 gene. This alteration results from a C to G substitution at nucleotide position 193, causing the arginine (R) at amino acid position 65 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at